The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells
Lin-Yan Wan,Hu Peng,Yi-Ran Ni,Xue-Ping Jiang,Jiao-Jiao Wang,Yan-Qiong Zhang,Lan Ma,Rui Li,Lin Han,Yong Tan,Jun-Ming Li,Wen-Li Cai,Wen-Fang Yuan,Jia-Jie Liang,Lu Huang,Xu Wu,Quan Zhou,Qi-Ni Cheng,Xue Yang,Meng-Yuan Liu,Wen-Bing Ai,Chang-Bai Liu,Hongbing Zhang,Jiang-Feng Wu
DOI: https://doi.org/10.1016/j.jcmgh.2022.01.016
IF: 8.797
2022-01-01
Cellular and Molecular Gastroenterology and Hepatology
Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND & AIMS">Hepatic fibrosis is characterized by hepatic stellate cell (HSC) activation and transdifferentiation-mediated extracellular matrix (ECM) deposition, which both contribute to cirrhosis. However, no antifibrotic regimen is available in the clinic. microRNA-23b/27b/24-1 cluster inhibition of transforming growth factor-β (TGF-β) signaling during hepatic development prompted us to explore whether this cluster inhibits HSC activation and hepatic fibrosis.</AbstractText>METHODS: <AbstractText Label="METHODS">Experimental fibrosis was studied in carbon tetrachloride (CCl<sub>4</sub>)-treated C57BL/6 mice. After administration of miR-23b/27b/24-1 lentivirus or vehicle, animals were euthanized for liver histology. In primary rat HSC and HSC-T6, the anti-fibrotic effect of miR-23b/27b/24-1 cluster was furtherly investigated by RNA-sequencing, luciferase reporter assay, western blotting and bioinformatic means.</AbstractText>RESULTS: <AbstractText Label="RESULTS">In this study, we showed that increasing the miR-23b/27b/24-1 level through intravenous delivery of miR-23b/27b/24-1 lentivirus ameliorated mouse hepatic fibrosis. Mechanistically, the miR-23b/27b/24-1 cluster directly targeted messenger RNAs, which reduced the protein expression of 5 secretory profibrotic genes (TGF-β2, Gremlin1, LOX, Itgα2, and Itgα5) in HSCs. Suppression of the TGF-β signaling pathway by down-regulation of TGF-β2, Itgα2, and Itgα5, and activation of the bone morphogenetic protein signaling pathway by inhibition of Gremlin1, decreased extracellular matrix secretion of HSCs. Furthermore, down-regulation of LOX expression softened the ECM. Moreover, a reduction in tissue inhibitors of metalloproteinase 1 expression owing to weakened TGF-β signaling increased ECM degradation.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS">Hepatic overexpression of the miR-23b/27b/24-1 cluster blocked hepatic fibrosis and may be a novel therapeutic regimen for patients with hepatic fibrosis.</AbstractText>
gastroenterology & hepatology